A Phase I Clinical Study of a Single Dose of KLA480

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 17, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

March 1, 2027

Conditions

Healthy Participants

Interventions

DRUG

KLA480 injection

Subcutaneous injection，Single dose

DRUG

Placebo

Subcutaneous injection，Single dose

Trial Locations (1)

RECRUITING

Huashan Hospital affiliated to Fudan University, Shanghai

All Listed Sponsors

lead

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

INDUSTRY